BRYCE BASS: Open Payments
NPI 1497307664 · FORT SMITH, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,096 in 127 payments from 19 companies in 2025. Trend: 2023 $2,444 · 2024 $1,837 · 2025 $2,096
Food & beverage: $1,917Education: $179
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 18 | $318 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 11 | $245 |
| Regeneron Healthcare Solutions, Inc. | 10 | $215 |
| ABBVIE INC. | 20 | $210 |
| Janssen Biotech, Inc. | 18 | $209 |
| Novartis Pharmaceuticals Corporation | 11 | $184 |
| LEO Pharma Inc. | 7 | $153 |
| GENZYME CORPORATION | 4 | $110 |
| PFIZER INC. | 6 | $98 |
| UCB, Inc. | 4 | $70 |
Products named: DUPIXENT, TALTZ, TREMFYA, COSENTYX, SKYRIZI, ILUMYA, ADBRY, CIBINQO.
Industry payments across AR — which companies pay providers there.
